Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAP.U
1751
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
| $19.3M | 0.01% |
+1,869,059
| New | +$19.1M |
|
1752
HSBC
HSBC
$365B
| $19.2M | 0.01% |
742,780
+722,659
| +3,592% | +$17.2M |
|
|
BHVN
1753
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $19.2M | 0.01% |
224,000
+127,100
| +131% | +$10.8M |
|
1754
CALL
Idexx Laboratories
IDXX
$44.1B
| $19.2M | 0.01% |
38,400
+6,500
| +20% | +$2.91M |
|
|
PMT
1755
PennyMac Mortgage Investment
PMT
$822M
| $19.2M | 0.01% |
1,089,378
+396,435
| +57% | +$6.72M |
|
1756
CALL
TripAdvisor
TRIP
$1.65B
| $19.2M | 0.01% |
665,500
+176,300
| +36% | +$4.24M |
|
1757
Maximus
MMS
$3.17B
| $19.1M | 0.01% |
261,561
+188,806
| +260% | +$13.4M |
|
1758
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $19.1M | 0.01% |
175,324
-40,976
| -19% | -$4.37M |
|
1759
CALL
Bausch Health
BHC
$2.58B
| $19.1M | 0.01% |
917,700
+83,100
| +10% | +$1.55M |
|
1760
CALL
Cardinal Health
CAH
$53.9B
| $19.1M | 0.01% |
356,100
-116,900
| -25% | -$6.07M |
|
1761
CALL
Mondelez International
MDLZ
$79.5B
| $19M | 0.01% |
325,600
-386,100
| -54% | -$22.1M |
|
1762
PUT
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$105M
| $19M | ﹤0.01% |
163,928
+100,428
| +158% | +$8.99M |
|
1763
Keros Therapeutics
KROS
$199M
| $19M | ﹤0.01% |
+269,243
| New | +$17M |
|
1764
Ralph Lauren
RL
$22.6B
| $19M | ﹤0.01% |
183,047
-72,550
| -28% | -$6.09M |
|
1765
CALL
Sysco
SYY
$40.8B
| $19M | ﹤0.01% |
255,700
-219,400
| -46% | -$15.1M |
|
|
XIFR
1766
XPLR Infrastructure LP
XIFR
$1.12B
| $18.9M | ﹤0.01% |
282,605
+111,805
| +65% | +$7.21M |
|
1767
CALL
Molson Coors Class B
TAP
$7.79B
| $18.9M | ﹤0.01% |
418,700
+147,300
| +54% | +$6.07M |
|
1768
PUT
Chubb
CB
$135B
| $18.9M | ﹤0.01% |
122,800
-35,000
| -22% | -$4.91M |
|
|
SPWR
1769
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $18.9M | ﹤0.01% |
736,800
+527,400
| +252% | +$10.7M |
|
|
1770
JPMorgan Chase
JPM
$935B
| $18.9M | ﹤0.01% |
148,596
-3,268,822
| -96% | -$365M |
|
1771
Regeneron Pharmaceuticals
REGN
$78.5B
| $18.9M | ﹤0.01% |
39,021
+23,016
| +144% | +$12.4M |
|
|
JOBS
1772
DELISTED
51job Inc
JOBS
| $18.8M | ﹤0.01% |
268,981
+114,131
| +74% | +$8.24M |
|
|
MNDT
1773
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $18.8M | ﹤0.01% |
815,900
+115,500
| +16% | +$1.78M |
|
1774
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $18.8M | ﹤0.01% |
1,064,734
-12,210
| -1% | -$214K |
|
1775
Guidewire Software
GWRE
$12.6B
| $18.8M | ﹤0.01% |
146,107
+120,545
| +472% | +$13.8M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.